Your First Week on Tirzepatide: What to Expect
A practical first-week checklist for tirzepatide: confirm your exact device, store it correctly, track symptoms, and know which signs need urgent care.

On this page
The short answer
In your first week on tirzepatide, the details that matter most are your exact device, correct storage, and knowing which symptoms need urgent care — not simply following a semaglutide routine with the drug name swapped. Confirm training for your specific pen, vial, or KwikPen, keep the prescribing instructions close, and never share an injection device with anyone else.
Know what needs urgent care this week
Tirzepatide's safety warnings apply from your first dose, not just after weeks of treatment. Read these before you do anything else.
Get emergency help right away for: swelling of the face, throat, or around the mouth or eyes; hives, rash, or itching along with trouble breathing or swallowing. Call your clinician immediately for: a lump or swelling in your neck, hoarseness, trouble swallowing, or unexplained shortness of breath — these are the symptoms tied to tirzepatide's thyroid tumor warning. Stop the medicine and seek prompt medical care for: stomach pain that will not go away, with or without vomiting, especially if it spreads to your back. Seek prompt assessment for: repeated vomiting, inability to keep fluids down, or a marked drop in urination. 1 2
For a suspected overdose in the United States, call Poison Help at 1-800-222-1222; call 911 for a life-threatening emergency. 2
None of this replaces your own medication guide. Keep it somewhere you can find it this week.
"Just like semaglutide" is the wrong assumption
Tirzepatide acts on two receptors — GIP and GLP-1 — rather than GLP-1 alone. 2 That difference matters less for your first week than a more practical one: the device in your hand. Zepbound ships as a single-dose pen, a single-dose vial, a multi-dose vial, or a single-patient-use KwikPen that holds four doses, and each presentation has its own handling instructions. 2
If your prescription changes presentation partway through treatment — say, from single-dose pens to a KwikPen — ask for training on the new device before you use it. Do not assume the steps carry over from one presentation to another, or from a different medicine entirely. 2 If you were reading about a first week on semaglutide before this appointment, set it aside: our semaglutide comparison explains where the two medicines genuinely differ, and our semaglutide first-week guide is written for that drug's own devices, not yours.
The device and storage details below describe Zepbound, the FDA-approved tirzepatide brand used for weight management. If you were dispensed a compounded tirzepatide preparation, its container, concentration, and storage instructions come from your dispensing pharmacy, not from Zepbound's label — ask your pharmacist for the instructions specific to what you received. Our compounded versus brand-name guide explains that distinction more generally.
Before your first injection
Confirm these before you use the medication:
| Check | Why it matters |
|---|---|
| Presentation | Pen, vial, or KwikPen — each has its own Instructions for Use. |
| Training | You have been shown your exact device and can repeat the steps back. |
| Appearance | The solution should be clear, colorless to slightly yellow, with no visible particles. |
| Injection site | Abdomen or thigh for self-injection; the back of the upper arm is for someone else to give it. |
| Medication list | Your clinician knows every other medicine you take, including any other GLP-1 or tirzepatide product. |
Tirzepatide is not meant to be combined with another GLP-1 receptor agonist or a second tirzepatide-containing product, so mention every prescription — including one from another clinician — before your first dose. 2
Never share a KwikPen with another person, even with a new needle attached. Sharing an injection device, however it looks cleaned, can spread infections carried in blood. 2
Store it correctly for your exact device
These windows are from Zepbound's current label and apply to Zepbound only. If you use a compounded preparation, follow your pharmacy's own storage and discard instructions instead — getting this wrong can mean using medication past when it is safe to, or discarding it too soon.
| Zepbound presentation | Refrigerated (36–46°F / 2–8°C) | Room temperature (up to 86°F / 30°C) |
|---|---|---|
| Single-dose pen or vial | Until the expiration date | Up to 21 days total, then discard |
| Multi-dose vial or KwikPen, unopened | Until the expiration date | Discard after 30 days |
| Multi-dose vial or KwikPen, opened | Either is fine | Discard after 30 days, or after 4 weekly doses, whichever comes first |
Never freeze Zepbound, and never use it if it has been frozen. 2
Keep a one-minute note
A short daily record helps a follow-up conversation more than memory does.
| Record | An example of useful detail |
|---|---|
| Injection | Date, time, and which device or presentation you used |
| Eating and drinking | What felt manageable, and whether a symptom got in the way |
| Symptoms | What happened, when it started, and how long it lasted |
| Questions | What to ask before your next scheduled dose |
"I felt off" is hard to act on. "Nausea started about an hour after the injection and eased by evening" gives your clinician something to work with.
What about nausea and other common symptoms?
Nausea, vomiting, diarrhea, constipation, abdominal pain, and injection-site reactions are the most commonly reported effects. 1 2 Tirzepatide's current prescribing information also warns that gastrointestinal reactions can sometimes be severe, and the medicine is not recommended if you have severe gastroparesis. 2 Mention any digestive symptom to your clinician rather than deciding on your own whether it counts as normal — a common side effect is still worth reporting. Our side-effect guide covers what to bring to that conversation.
If you use oral hormonal contraception
Tirzepatide slows stomach emptying, which can reduce how well an oral contraceptive pill is absorbed. If you take one, plan to add a barrier method or switch to a non-oral method for four weeks after starting and for four weeks after each dose increase your clinician makes. Non-oral hormonal methods — a patch, ring, or injection — are not expected to be affected. Confirm this with your own prescriber rather than applying it to a form of birth control it was not written for. 2
Before your next scheduled dose
Review your notes. Is any symptom severe, ongoing, or affecting your eating and drinking? Do you know whether your clinician wants to hear from you before the next injection?
If you are unsure whether a dose was given, think you missed one, or are not sure how much time has passed, contact your clinician or pharmacist for instructions specific to your presentation. Do not guess, and do not borrow a semaglutide routine or a friend's tirzepatide schedule as a substitute. 2
For the fuller 90-day view, including follow-up timing and what to bring to each visit, see our first 90 days planner. Our food guide can help if eating feels different this week.
Common questions
Can I use my Zepbound KwikPen for a family member who is also prescribed it?
No. Never share an injection device between people, even if you change the needle. It can spread infections carried in blood. 2
Does tirzepatide's higher average weight loss in trials mean I should expect faster results this week?
No. Trial averages describe a study group over many months, not an individual first week. See our semaglutide vs. tirzepatide comparison for what that evidence does and does not tell you.
Should I take an extra dose if I am still hungry before the week is out?
No. Use only the amount your clinician prescribed, and report ongoing hunger or other concerns at your next contact instead of adjusting it yourself.
References
- Tirzepatide Injection — MedlinePlus, U.S. National Library of Medicine
- Zepbound Prescribing Information — Eli Lilly and Company
For your information. This article provides general education and does not replace medical advice or an individual evaluation. Talk to your clinician before starting, changing, or stopping treatment. Compounded medications are not FDA-approved.